Passage Bio, Inc. (PASG) Total Return Calculator with Dividends Reinvested

Passage Bio, Inc.

Popular:

The total return for Passage Bio, Inc. (PASG) stock is -28.43% over the past 12 months. So far it's down 52.18% this year. The 5-year total return is -98.05%, meaning $10,000 invested in PASG stock 5 years ago would be worth $195 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in PASG 1 year ago, it would be worth $7,148 today — you'd have lost $2,852.

With Dividends Reinvested$7,148-28.52%

Price Only (No DRIP)$7,148-28.52%

Period2025-06-20 → 2026-06-18

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in PASG

1Y$7,157-$2,843 (-28.4%)-28.4% CAGR

3Y$3,015-$6,985 (-69.8%)-32.9% CAGR

5Y$195-$9,805 (-98.1%)-54.5% CAGR

10Y$126-$9,874 (-98.7%)-35.4% CAGR

15Y$126-$9,874 (-98.7%)-25.3% CAGR

20Y$126-$9,874 (-98.7%)-19.6% CAGR

30Y$126-$9,874 (-98.7%)-13.6% CAGR

Passage Bio, Inc. did not pay dividends during this period. Total return = price return.

Loading PASG total return...

As of 2026-06-19

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-52.18%	—	-52.18%	—	$4,782
1Y	-28.43%	-28.43%	-28.43%	—	$7,157
3Y	-69.85%	-32.94%	-69.85%	—	$3,015
5Y	-98.05%	-54.52%	-98.05%	—	$195
10Y	-98.74%	-35.43%	-98.74%	—	$126
15Y	-98.74%	-25.30%	-98.74%	—	$126
20Y	-98.74%	-19.65%	-98.74%	—	$126
30Y	-98.74%	-13.57%	-98.74%	—	$126

Risk & Highlights

Best Year+15.18%2020

Worst Year-78.74%2022

Max Drawdown-79.45%2026-01-09 → 2026-05-07

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-21.98%	-21.98%	—	+0.41%	-22.4pp
2025	-28.92%	-28.92%	—	+16.64%	-45.6pp
2024	-37.07%	-37.07%	—	+24.00%	-61.1pp
2023	-37.65%	-37.65%	—	+24.81%	-62.5pp
2022	-78.74%	-78.74%	—	-19.95%	-58.8pp

PASG underperformed the S&P 500 by 53.42pp over the past year (-28.43% vs +24.99%).

Loading summary...

PASG Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
PASGPassage Bio, Inc.	$18M	+9.2%	-52.2%	-28.4%	—	-69.8%	-98.1%	-98.7%
KRYSKrystal Biotech, Inc.	$10.3B	+19.3%	+41.0%	+163.5%	—	+179.0%	+433.0%	+3171.2%
RCKTRocket Pharmaceuticals, Inc.	$366M	+9.1%	-3.2%	+18.4%	—	-85.2%	-92.2%	-89.0%
RAREUltragenyx Pharmaceutical Inc.	$2.7B	+13.4%	+16.3%	-26.5%	—	-45.3%	-71.1%	-49.7%
FOLDAmicus Therapeutics, Inc.	$4.5B	—	+1.5%	+152.9%	—	+12.1%	+45.9%	+145.2%
ACADACADIA Pharmaceuticals Inc.	$3.7B	+4.5%	-17.3%	-5.8%	—	-9.3%	-16.9%	-42.2%
PRAXPraxis Precision Medicines, Inc.	$8.2B	-11.9%	-1.4%	+557.0%	—	+1611.0%	-12.5%	-32.3%
SGMOSangamo Therapeutics, Inc.	$75M	+41.1%	-59.1%	-63.3%	—	-84.9%	-98.4%	-96.9%
ARWRArrowhead Pharmaceuticals, Inc.	$11.5B	+10.6%	+20.7%	+423.8%	—	+128.7%	-4.5%	+1291.5%
NTLAIntellia Therapeutics, Inc.	$1.8B	+23.5%	+70.1%	+63.2%	—	-64.1%	-79.4%	-43.2%
BEAMBeam Therapeutics Inc.	$3.5B	+27.3%	+25.8%	+100.9%	—	+2.4%	-59.8%	+82.1%

Compare:PASG vs KRYS PASG vs RCKT PASG vs RARE PASG vs KRYS vs RCKT

About PASG Dividend Returns

Passage Bio, Inc. (PASG) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of PASG over the past year?

Passage Bio, Inc. (PASG) delivered a return of -28.43% over the past year. Since PASG does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in PASG be worth today?

A $10,000 investment in Passage Bio, Inc. one year ago would be worth $7,157 today, representing a loss of $2,843.

Q3Does PASG pay dividends?

Passage Bio, Inc. (PASG) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PASG, the total return equals the price-only return.

Q4Did PASG beat the S&P 500?

No, Passage Bio, Inc. (PASG) underperformed the S&P 500 by 53.42 percentage points over the past year. PASG delivered a total return of -28.43%, compared to the S&P 500's 24.99%. This means a passive S&P 500 index fund outperformed PASG by 53.42pp during this period.

Q5What is PASG's worst drawdown?

Passage Bio, Inc. (PASG) experienced a maximum drawdown of -79.45% over the past year, declining from its peak on 2026-01-09 to its trough on 2026-05-07. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is PASG's long-term total return over 10, 20, or 30 years?

Here are Passage Bio, Inc. (PASG)'s long-term returns with dividends reinvested. Over 10 years, the total return is -98.7% (-35.4% CAGR) — $10,000 would have grown to $126. Over 20 years: -98.7% total return (-19.6% CAGR) — $10,000 → $126. Over 30 years: -98.7% total return (-13.6% CAGR) — $10,000 → $126. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was PASG's best and worst year?

Passage Bio, Inc.'s best calendar year was 2020 with a total return of 15.2%. Its worst year was 2022 with a total return of -78.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 93.9 percentage points.

How much would $100/month in PASG be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →